✦ LIBER ✦

587 Phase 1 Dose-escalation Study of PF-04449913, an Oral Hedgehog Inhibitor in Patients with Select Solid Tumors

✍ Scribed by Wagner, A.; Messersmith, W.; Shaik, N.; Zheng, X.; McLachlan, K.; Cesari, R.; Courtney, R.; Levin, W.; El-Khoueiry, A.

Book ID: 122601142
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 66 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72384-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I, Dose-Escalation Study of BKM120

Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors

✍ Bendell, J. C.; Rodon, J.; Burris, H. A.; de Jonge, M.; Verweij, J.; Birle, D.; 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

1243 Phase I dose-escalation study of co

1243 Phase I dose-escalation study of continuous oral treatment with the angiokinase inhibitor BIBF 1120 in patients with advanced solid tumors

✍ H. Kaneda; I. Okamoto; T. Satoh; T. Arao; K. Nishio; A. Sarashina; K. Konishi; P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Phase I dose-escalation study of the HSP

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors

✍ Toshihiko Doi,Yusuke Onozawa,Nozomu Fuse… 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 733 KB

Phase I dose-escalation and -expansion s

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

✍ Rodon, Jordi; Braña, Irene; Siu, Lillian L; Jonge, Maja J; Homji, Natasha; Mills 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 925 KB

608 Phase I Dose-escalation Trial of a S

608 Phase I Dose-escalation Trial of a Selective Oral MEK1/2 Inhibitor, Pimasertib (MSC1936369B), Combined with an mTOR Inhibitor, Temsirolimus, in Patients with Advanced Solid Tumors

✍ Naing, A.; Mita, M.; Komarnitsky, P.; Milner, A.; von Richter, O.; Ogden, J.; Pi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

1246 POSTER A Phase I Dose-escalation St

1246 POSTER A Phase I Dose-escalation Study of EMD 1214063, an Oral Selective C-Met Inhibitor, in Patients With Advanced Solid Tumours

✍ G.S. Falchook; S. Fu; H.M. Amin; S.A. Piha-Paul; D.S. Hong; A. Naing; M.B. Kleve 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB